Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
oncology
rare diseases |
| gptkbp:foundedYear |
1985
|
| gptkbp:headquartersLocation |
gptkb:Los_Angeles,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
aldoxorubicin
|
| gptkbp:stockSymbol |
gptkb:CYTR
|
| gptkbp:tradedOn |
gptkb:OTCQB
|
| gptkbp:website |
https://www.cytrx.com/
|
| gptkbp:bfsParent |
gptkb:LadRx_Corporation
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
CytRx Corporation
|